chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 5 minutes after patient got vaccinated.  Pt states feeling not able to control of of walking, dizzy, feels faint, feels palpitations and major headache. Has chronic history of migraines and headaches. Had headache before getting the vaccine. Patient laid down and still did not feel better, pt able to talk in normal sentences without respiratory distress. Paramedics arrived. Vitals normal. Blood sugar normal (108 mg/dL). No known allergies. Pt takes BP meds, synthesis for thyroid, bupropion for depression and fibromyalgia. Pt stable and was wheel-chaired to car where her husband was at.
Erythema at site of injection. Discrete satellite papules that were erythematous. Non-confluent at time of examination.
Rash or burn under left arm, started on 06/07/2021, same arm of vaccine.
Sweats began, low grade fever, all over body aches. Continued through 8/12/15.
9/14/2010 pt. reports received Tdap to left arm on 9/09/2010.  Vaccine site was fine until 9/11/10 when she noticed the site is hard, red and warm and about the size of a quarter.  States it's about the same or better today, no worse. Advised to F/U with PMD if no improvement.
Pt had difficulty breathing approximately 5 to 10 minutes after receiving the vaccine.  An EpiPen was administered and the patients symptoms began to improve and then EMS took over care.
This spontaneous report was received from a Registered Nurse referring to a 32 year old female patient. No information regarding the patient's concomitant therapies was provided. The patient did not have pre-existing physician diagnosed allergies, birth defects or medical conditions. On 01-DEC-2017, the patient was vaccinated with the firs dose of VARIVAX subcutaneous, lot # M038857, lot expiration: 14-SEP-2018 (strength and anatomical location were not provided) for prophylaxis. Other suspect therapies included sterile diluent (manufacturer unknown). On 06-DEC-2017 (also reported as: "5 days after vaccination"), there was a positive unspecified pregnancy test, however no adverse event was reported.
12 hours after 2nd dose I ran a fever consistently for about 24 hours, had a headache body aches chills and congestion.  After 24 hours of the fever I feel completely normal.
I caught what I thought was  a cold and then began to feel not well. I had a low grade fever, chills, a very bad headache, my ears hurt as well. I had another family member test positive for COVID-19 after testing myself I tested positive for COVID-19 as well. This the second time I tested positive for COVID-19 and it is much worse this time with multiple symptoms.  Loss of smell or smell and taste disorder as well.
This literature marketed report has been received from the authors of a published literature article, concerning a 55-year-old male patient. No information regarding the patient's medical history or concurrent conditions was provided. The patient was a part of a retrospective analysis that studied the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on the incidence of invasive pneumococcal disease (IPD) in cancer patients, along 20 years. The patients included were registered with at least 1 visit between 01-JAN-1992 and 31-DEC-2012. Unique patient-visits (UPV) (inpatient or outpatient) per calendar year, age, and cancer type were obtained from hospital databases. However, non-cancer patients were also included. Patients <15 years were considered "children", and at least 15 years old were "adults". Children 0-4 years were referred to as "vaccinees", and patients at least 5 years old were "non-vaccinees". The IPD incidences were categorized as "before PCV7" (occurred between 1992-2000), "after PCV7" (2001-2010) and "after PCV13" (2011-2012). The authors observed an abrupt decline in the incidence of IPD in 2000, coinciding with the introduction of PCV7. It remained relatively stable through 2010. The IPD incidence declined after PCV7 in children 0-4 years (vaccinees) and in at least 5 year old patients with hematologic malignancies (non-vaccinees). This suggested an indirect effect of routine childhood immunization with PCV7. They suggested that continued surveillance is warranted to characterize the burden of IPD in the era of PCV13 and optimize preventive strategies in highly immunocompromised patients. On 26-JAN-1996, the patient was vaccinated with a dose of PNEUMOVAX 23 injection (dose and route of administration were not reported). There were no concomitant therapies reported. On 01-JUN-1996 ("before PCV7"), the patient was found to have invasive pneumococcal disease (type 15; one of the vaccine serogroups). The patient was hospitalized due to the event on an unknown date (approximately in June 1996), and received unspecified prescription drug treatment. He recovered from the event on 13-JUN-1996. The authors considered the event of invasive pneumococcal disease to be medically significant (as it required medical/surgical intervention to prevent one of the serious outcomes) and related to the vaccination with PNEUMOVAX 23. The physician stated that no further information was available. It was a study done via chart records from over 5 years ago, and those records were no longer available at the time of contact. This is one of several reports derived from the same literature (linked reports MARRS# 1802USA000459, 1803USA007151). Sender's Comments: US-009507513-1802USA000459.
Information has been received from a healthcare worker concerning a 5 week old patient who was vaccinated with ROTATEQ vaccine live (human-bovine) (date, dose unspecified). No adverse effect reported. It is unknown if medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
First day - chills fever couldn't get out of the bed, couldn't eat. 3 rd day - I got fever blisters on inside and outside of mouth swollen area of mouth, roof of mouth felt like pizza burn. Lasted for a week slowly went away. Drank fluids with straw.
pt called ~ 24 hours after injection w/ complaints of swelling/tightness/itching of the injection site and fever & chills starting about 8-10 hours from the time of vaccination
Itching started 2 hours after injection. Chest, then back. Got worse in the middle of the night- groin and ankles very itchy.  1 week later (today) itchiness periodically continues - ankles, wrists, chest, scalp, groin. 24 hours after injection I had the most severe headache I?ve ever experienced, that strangely was worse when lying down. 2 Advil and propping myself in a sitting position to sleep helped it go away, and it hasn?t returned. It was so sudden (woke me up) and so severe that I had considered going to the ER since I already had experienced one adverse reaction to the vaccination. The headache was bilateral and felt like swelling at the top of my cervical spine and bottom of my occipital bone. Standing and moving my head temporarily decreased the pain and nausea, but I think Advil really helped the most.
Arm is extremely red; Looks like a birth mark/I looks like a 'bruise', like birth mark on it.; This is a spontaneous report from contactable consumer. This consumer reported for 20-years-old patient that:  A 20-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: FA6780, Expiry date: Unknown) via an unspecified route of administration in arm right on 01Aug2021 (at the age 20-year-old) at 4 or 5 pm as dose 1, single for COVID-19 immunization. Medical history included patient had Pfizer shot and 2 weeks ago her arm extremely "swelled" up and red (looks like yesterday took shot). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Second shot due ate around 22 or something. Investigation assessment was not reported. On 01Aug2021 patient experienced arm is extremely red; Looks like a birth mark/I looks like a 'bruise', like birth mark on it. The patient didn't received treatment for events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
approx 3 days p/ vax pt devel about 30 lesions. seen by MD 10 days later & lesions scabbed over.
Per medical records, patient was admitted to hospital on 08/25/2021 denying chronic illness or medications who presented with 3 weeks of gait instability, BUE weakness, subjective fever/chills, nausea, cough with phlegm, and SOB. Patient was a former smoker. Per medical records, the patient was emergently intubated and required admission to the ICU. Patient expired on 09/15/2021. Patient was fully vaccinated with J&J
Allodynia (pain to light touch) on extensor side of both upper extremities (overlying triceps)
very hard to breath; 42 days interval from the first shot; extreme dizziness; extreme looseness; sweating a lot; confusion over 5 weeks; sweating a lot; it got worst a really bad reaction; horrific joint pain; fever 100.1 degrees Fahrenheit; nauseous; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness) and the first episode of HYPERHIDROSIS (sweating a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), the first episode of HYPERHIDROSIS (sweating a lot), CONFUSIONAL STATE (confusion over 5 weeks), the second episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (very hard to breath), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), CONFUSIONAL STATE (confusion over 5 weeks), the last episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot) had resolved.            Patient went to ER but they did not do anything.The patient is allergic to other things, not taking any vitamins and doesn't want to provide her medications. no treatment and concomitant medications were reported  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-186627 (Patient Link).
fever 103.8 ax, accompanied by irritability, loss of appetite duration unk; fever dec w/APAP
This spontaneous report as received from a nurse practitioner refers to a 4-month-old patient of unknown gender. No information on patient's medical history or concomitant conditions was provided. On 22-DEC-2014, the patient was vaccinated with a dose of LIQUID PEDVAXHIB (lot # K008680, dose, strength, route of administration and expiration date were not reported) which had temperature excursion (incorrect product storage). The lot source was public. No information on patient's concomitant medication was provided. There was no adverse event experienced. This is one of several reports received from the same reporter. Additional information has been requested.
I started hearing an odd sound like something scratching at something in the distance. I got up to find the source and noticed that as I moved my eyes from side to side I could hear the sound. Everytime I quickly move my eyes from side to side I can hear them move. I have had a continuous headache since the day after I received my shot and today also started having immense pain in the lymph node of my left armpit. The sound coming from the movement of my eyes however is making it quite difficult to function. It makes my nauseous and my head continues to hurt.
This case was reported by a nurse and described the occurrence of fever in a 2 month old male pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. The pt had no relevant medical history, concurrent conditions, or concurrent medications. On 02July2003, the pt received the first dose of Infanrix. This vaccine had inadvertently been left unrefrigerated for an unspecified period of time. On the same date, he also received his first injections of Haemophilus influenzae type b conjugate vaccine, inactivated poliomyelitis virus vaccine (IPOL), and 7 valent pneumococcal conjugate vaccine (Prevnar). On 03July2003, 24 hours post immunization, the pt developed a fever and an injection site reaction characterized by swelling and redness. The pt was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix.
This case was reported by a pharmacist via call center representative and described the occurrence of blister in a 77-year-old male patient who received Shingrix (batch number G47M2, expiry date 11th October 2020) for prophylaxis. Previously administered products included Zostavax (Zostavax vaccine received about 4 years ago approximately per the patient). On 10th May 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In June 2018, 30 days after receiving Shingrix, the patient experienced blister and pain. On an unknown date, the outcome of the blister was recovered/resolved and the outcome of the pain was not recovered/not resolved. It was unknown if the reporter considered the blister and pain to be related to Shingrix. Additional details werre provided as follows: The patient received the first dose of the Shingrix at approximately 2:00 PM on left deltoid. The pharmacist had a patient report that a month after receiving the Shingrix vaccine, he experienced painful fluid filled blisters on his lower back and right hip on the right side. The blisters popped and eventually healed. The patient had no pain now but the blisters were painful at the time. The patient did not receive medical care for the blisters.
Patient was admitted 2 days after 2nd dose of Pfizer vaccine with  right-sided facial weakness, numbness in addition to headache and found on imaging to have central venous thrombosis, he was started on OAC and got better and discharged home.
pt recv vax 31OCT97 & 2NOV97 pt exp sudden extreme vertigo;pt went to ER on 3NOV97;pt was adm to trauma & released the same evening;4NOV97 pt exp an inc in blood pressure;
tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.
Received 2nd dose of Shindrix vaccine @ 10 a.m. As with the 1st dose on 10/31/19, my arm from shoulder to elbow became very sore with a constant nerve like ache. In the early evening, I began severe chills and a severe intractable headache, followed by generalized and severe muscle aching with some muscle contractions in extremities. All the above lasted over 16 hr. The headache did not subside entirely until this a.m. about 10 a.m. I am still weak and perspire if I expend any energy. I have never had any body aches as severe as these were! The injection site never became swollen or reddened, and I did not develop an elevated temp. Not sure if this was due to the immunization but was feeling fine and healthy, not in contact with any known person with sxs.
Severe pain, muscle/joint focus. Severe headache. Severe shivering. Fever sensation, temperature unknown. Partial paralysis both legs, spastic gait, extreme difficulty walking. Confusion, chaotic thinking. Impaired sleep. Severe anxiety. Period of subsidence/resolution, 03.0 hours after ibuprofen 400 mg. Overall duration 06.0 hours. No discernible permanent effects. Impression of impending recurrence on following night. Inconsequential after ibuprofen 200 mg.
Patient with cancer came for Moderna booster shot 10/26/2021. Patient was giving 0.25 ml of Moderna vaccine instead of 0.5 ml
vision began to be greatly enhanced; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 03Apr2021 at 13:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient included penicillin allergy. Concomitant medications included atorvastatin calcium (LIPITOR) from unknown date, for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 13:30 the patient experienced that his vision began was greatly enhanced (altered visual depth perception).  He could see details like never before. Colors were brighter, more sharp and distinct. As best as the patient could describe it, he could see dimensionally, as in multi layers. On 06Apr2021, the patient did not even need reading glasses at all. His vision kept improving. The patient did not receive any treatment for the reported event.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vision began to be greatly enhanced was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
32 year old female presents ambulatory to clinic with complaints of a sore left arm. Patient states that it became sore after she got the flu shot on 10/03/2014. She states it has slowly gotten worse to where she has a hard time moving arm. Patient has been taking Tylenol.
Post vax, the patient experienced bilateral knee pain, bilateral foot pain and right prepatella effusion.
pt recvd vax 31AUG95;31OCT95 lab eval revealed IgG <8 & IgM <10;pt did not devel antibodies to varicella;
Within first 12-24 hours:  tiredness, chills, mild headache  Within 24-28 hours:  continued fatigue, mild headache  Within 36 hours:  developed large golf-ball sized lymph node lump, below right armpit, in additon to above symptoms beginning to lessen
Accidentally administered Pfizer monovalent when patient came to get booster dose. Error realized shortly post administration, patient counseled and given bivalent dose during same visit.
Pt recv vax on 1/8/98; on same day pt exp tingling & numbness of arm; 1/9/98 pt exp rash on face & neck x 24-48 hr
-7:10 pm Varivax #2 7:20 pm obvious increased RR, increased WOB, hear continuous cough, I & E wheeze 7:22 pm Benadryl (12.5 mg/5cc) 2 1/2 tsp PO Orapred (15 mg/5cc) 3 tsp PO O2 Sat 98% RA Xopenex 1.25 mg with 6 liters O2 via mask faint expiratory wheeze +/o decreased RR Ambulance arrive 7:28 pm, transported to hospital ED
48 hours after having an influenza vaccination she developed itching followed by red spots, over torso and scalp.
sore arm (from first dose); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm (from first dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L2074) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm (from first dose)). At the time of the report, PAIN IN EXTREMITY (sore arm (from first dose)) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-116496.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Dose 1 details were added.
gout flair up in right foot; 3rd day after shot, right knee was hurting for several days; This is a spontaneous report received from a contactable consumer, the patient. A 27-Year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) as a single dose via an unspecified route of administration in his left arm on 12Mar2021at 10:45AM (at the age of 27-year-old), for COVID-19 immunisation. The patients medical history included immune compromised, no functioning pituitary gland. The patient was allergic to iodine. Concomitant medications included hydrocortisone(MANUFACTURER UNKINOWN), levothyroxine(MANUFACTURER UNKNOWN), testosterone(MANUFACTURER UNKNOWN). The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not tested positive for COVID-19 since having the vaccine. The patient had not diagnosed with COVID-19 prior to vaccination.  On 15Mar2021, the patient reported that he had right knee pain and gout flare up in right foot. It was reported that on 3rd day after vaccination the right knee was hurting for several days and then after 3-4 days later, he could not walk due to a gout flare up in right foot. Therapeutic measure were provided for the reported events with unspecified medications. The clinical outcome right knee pain and gout flare was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.